News

MARINOMED RESUMES OFFER PERIOD OF INITIAL PUBLIC OFFERING ON THE VIENNA STOCK EXCHANGE

Listeria in the feed: A dangerous hygiene problem in fattening pigs

Marinomed: Partnership in China and EIB Financing

Valneva Confirms FY 2018 Guidance and Provides Initial Product Sales Revenue Guidance for 2019

Valneva Announces New $59 Million IXIARO® Supply Contract with US Government

Herbal antioxidants are becoming increasingly important

123sonography Acquires the SonoWorld Website from Inteleos

AOP Orphan Pharmaceuticals AG and Chord Therapeutics Announce a Partnership to Develop CRD1 (Cladribine) for Treatment of Orphan Autoimmune Diseases

Valneva Announces its Intention to Delist from the Vienna Stock

Valneva Announces its Intention to Delist from the Vienna Stock

HOOKIPA Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead

Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate

Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate

Curetis’ Subsidiary Ares Genetics Teams Up with Leading

Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate

HOOKIPA Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus

AOP Orphan announces positive CHMP opinion for Ropeginterferon alfa-2b/BESREMi®

AddLife acquires Austrian Biomedica – international expansion on 13 new markets

Small but versatile – Key players in the marine nitrogen cycle can utilize cyanate and urea

Valneva and HOOKIPA Sign a Collaboration and Manufacturing Agreement